TPB · Turning Point Brands, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $0.23 | Q2 2026 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | $15.2M | Q2 2026 | — |
|
|
|||
| Net debt | $31.7M | Q2 2026 | — |
| Total liquidity | $339M | Q2 2026 | — |
| Asset backed revolving credit facility capacity | $68.1M | As of December 31, 2025 | — |
| Modern Oral Net Sales | $41.3M | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Tobacco — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TPB
this stock
Turning Point Brands, Inc.
|
$1.73B | -18.6% | +28.4% | 27.8 | 13.0% |
|
PM
Philip Morris International Inc.
|
$292.53B | +18.4% | +7.3% | 27.0 | 1.0% |
|
BTI
British American Tobacco p.l.c.
|
$121.50B | -1.1% | — | — | 0.3% |
|
MO
Altria Group, Inc.
|
$106.80B | +14.5% | -3.1% | 13.5 | 3.0% |
|
RLX
RLX Technology Inc.
|
$2.22B | -21.5% | +50.3% | — | 0.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TPB | +2.3% | +12.6% | -37.8% | +18.3% | -18.6% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +2.7% | +9.7% | -49.4% | +15.4% | -31.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.